Lung function and respiratory diseases in people with psychosis: Population-based study

British Journal of Psychiatry

Volumn 207, Issue 1, 2015, Pages 37-45

  Partti, Krista ^a,b   Vasankari, Tuula ^c   Kanervisto, Merja ^d   Perälä, Jonna ^a,e   Saarni, Samuli I ^a,f   Jousilahti, Pekka ^a   Lönnqvist, Jouko ^a,b   Suvisaari, Jaana ^a,g  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c Finnish Lung Health Association   (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f HOSPITAL DISTRICT OF SOUTHWEST FINLAND   (Finland)

^g UNIVERSITY OF TAMPERE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

COTININE;

ADULT; AFFECTIVE PSYCHOSIS; ARTICLE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; FEMALE; HUMAN; INFLUENZA VACCINATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; POPULATION RESEARCH; PSYCHOSIS; RESPIRATORY TRACT DISEASE; SCHIZOPHRENIA; SMOKING; SPIROMETRY; BRONCHITIS, CHRONIC; COMPLICATION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FINLAND; MIDDLE AGED; ODDS RATIO; SELF REPORT; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

ADULT; BRONCHITIS, CHRONIC; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FINLAND; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; ODDS RATIO; PNEUMONIA; SCHIZOPHRENIA; SELF REPORT; SMOKING; SPIROMETRY;

EID: 84937243127     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.113.141937     Document Type: Article

References (47)

1. Green R. Asthma and manic depressive psychosis-simultaneously incompatible or coexistent? J Nerv Ment Dis 1965; 140: 64-70.
2. Suvisaari J, Perala J, Saarni SI, Harkanen T, Pirkola S, Joukamaa M, et al. Type 2 diabetes among persons with schizophrenia and other psychotic disorders in a general population survey. Eur Arch Psychiatry Clin Neurosci 2008; 258: 129-36.
3. Partti K, Heliövaara M, Impivaara O, Perälä J, Saarni SI, Lönnqvist J, et al. Skeletal status in psychotic disorders: a population-based study. Psychosom Med 2010; 72: 933-40.
4. Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry 2007; 64: 1123-31.
5. Brown S, Kim M, Mitchell C, Inskip H. Twenty-five year mortality of a community cohort with schizophrenia. Br J Psychiatry 2010; 196: 116-21.
6. Crump C, Winkleby MA, Sundquist K, Sundquist J. Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am J Psychiatry 2013; 170: 324-33.
7. Himelhoch S, Lehman A, Kreyenbuhl J, Daumit G, Brown C, Dixon L. Prevalence of chronic obstructive pulmonary disease among those with serious mental illness. Am J Psychiatry 2004; 161: 2317-19.
8. Carney CP, Jones L, Woolson RF. Medical comorbidity in women and men with schizophrenia: a population-based controlled study. J Gen Intern Med 2006; 21: 1133-7.
9. Copeland LA, Mortensen EM, Zeber JE, Pugh MJ, Restrepo MI, Dalack GW. Pulmonary disease among inpatient decedents: impact of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 720-6.
10. Chen YH, Lee HC, Lin HC. Prevalence and risk of atopic disorders among schizophrenia patients: a nationwide population based study. Schizophr Res 2009; 108: 191-6.
11. Hsu JH, Chien IC, Lin CH, Chou YJ, Chou P. Increased risk of chronic obstructive pulmonary disease in patients with schizophrenia: a population-based study. Psychosomatics 2013; 54: 345-51.
12. Filik R, Sipos A, Kehoe PG, Burns T, Cooper SJ, Stevens H, et al. The cardiovascular and respiratory health of people with schizophrenia. Acta Psychiatr Scand 2006; 113: 298-305.
13. Vancampfort D, Probst M, Stubbs B, Soundy A, De Herdt A, De Hert M. Associations between expiratory spirometry parameters and limitations in daily life activities in patients with schizophrenia. Gen Hosp Psychiatry 2014; 36: 172-6.
14. Vancampfort D, Probst M, Stubbs B, Soundy A, De Herdt A, De Hert M. Metabolic syndrome and lung function in schizophrenia: a pilot study. Psychiatry Res 2014; 220: 58-62.
15. Dalack GW, Healy DJ, Meador-Woodruff JH. Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings. Am J Psychiatry 1998; 155: 1490-501.
16. Kalman D, Morissette SB, George TP. Co-morbidity of smoking in patients with psychiatric and substance use disorders. Am J Addict 2005; 14: 106-23.
17. World Health Organization, National Heart, Lung, and Blood Institute. Global strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2014 (http://www.goldcopd.org/).
18. Wannamethee SG, Shaper AG, Whincup PH. Body fat distribution, body composition, and respiratory function in elderly men. Am J Clin Nutr 2005; 82: 996-1003.
19. Van den Borst B, Gosker HR, Zeegers MP, Schols AMWJ. Pulmonary function in diabetes: a meta-analysis. Chest 2010; 138: 393-406.
20. Aromaa A, Koskinen S. Health and Functional Capacity in Finland. Baseline Results of the Health 2000 Health Examination Survey. National Public Health Institute, 2004 (http://www.terveys2000.fi/julkaisut/baseline.pdf).
21. First MB, Spitzer RL, Gibbon M, Williams, JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Patient Edition (SCID I/P). Biometrics Research Department, New York State Psychiatric Institute, 2001.
22. Heistaro S (ed). Methodology Report. Health 2000 Survey. National Public Health Institute, 2008 (http://www.terveys2000.fi/doc/methodologyrep.pdf).
23. Perälä J, Suvisaari J, Saarni SI, Kuoppasalmi K, Isometsä E, Pirkola S, et al. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry 2007; 64: 19-28.
24. Wittchen HU, Lachner G, Wunderlich U, Pfister H. Test-retest reliability of the computerized DSM-IV version of the Munich-Composite International Diagnostic Interview (M-CIDI). Soc Psychiatry Psychiatr Epidemiol 1998; 33: 568-78.
25. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn, revised) (DSM-IV-TR). APA, 2000.
26. Vasankari TM, Impivaara O, Heliövaara M, Heistaro S, Liippo K, Puukka P. No increase in the prevalence of COPD in two decades. Eur Respir J 2010; 36: 766-73.
27. Viljanen A. Reference values for spirometric, pulmonary diffusing capacity and body pletysmografic studies. Scand J Clin Lab Invest 1982; 42 (suppl 159): s5-20.
28. World Health Organization. International Statistical Classification of Diseases and Related Health Problems (ICD-9). WHO, 1978.
29. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. WHO, 1992.
30. Keskitalo K, Broms U, Heliovaara M, Ripatti S, Surakka I, Perola M, et al. Association of serum cotinine level with a cluster of three nicotinic acetylcholine receptor genes (CHRNA3/CHRNA5/CHRNB4) on chromosome 15. Hum Mol Genet 2009; 18: 4007-12.
31. Vartiainen E, Seppälä T, Lilsunde P, Puska P. Validation of self reported smoking by serum cotinine measurement in a community-based study. J Epidemiol Community Health 2002; 56: 167-70.
32. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of The Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
33. Suvisaari JM, Saarni SI, Perälä J, Suvisaari JV, Härkänen T, Lönnqvist J, et al. Metabolic syndrome among persons with schizophrenia and other psychotic disorders in a general population survey. J Clin Psychiatry 2007; 68: 1045-55.
34. Scarlata S, Pedone C, Fimognari FL, Bellia V, Forastiere F, Incalzi RA. Restrictive pulmonary dysfunction at spirometry and mortality in the elderly. Respir Med 2008; 102: 1349-54.
35. Guerra S, Sherrill DL, Venker C, Ceccato CM, Halonen M, Martinez FD. Morbidity and mortality associated with the restrictive spirometric pattern: a longitudinal study. Thorax 2010; 65: 499-504.
36. Paek YJ, Jung KS, Hwang YI, Lee KS, Lee DR, Lee JU. Association between low pulmonary function and metabolic risk factors in Korean adults: the Korean National Health and Nutrition Survey. Metabolism 2010; 59: 1300-6.
37. Seminog OO, Goldacre MJ. Risk of pneumonia and pneumococcal disease in people with severe mental illness: English record linkage studies. Thorax 2013; 68: 171-6.
38. Healy D, Le Noury J, Harris M, Butt M, Linden S, Whitaker C, et al. Mortality in schizophrenia and related psychoses: data from two cohorts, 1875-1924 and 1994-2010. BMJ Open 2012; 2: e001810.
39. DE Hert M, Correll CU, Bobes J, Cetkovich-Bakmas M, Cohen D, Asai I, et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry 2011; 10: 52-77.
40. Koivula I, Sten M, Makela PH. Risk factors for pneumonia in the elderly. Am J Med 1994; 96: 313-20.
41. Benros ME, Nielsen PR, Nordentoft M, Eaton WW, Dalton SO, Mortensen PB. Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study. Am J Psychiatry 2011; 168: 1303-10.
42. Chen YH, Lin HC, Lin HC. Poor clinical outcomes among pneumonia patients with schizophrenia. Schizophr Bull 2011; 37: 1088-94.
43. Trifiro G, Gambassi G, Sen EF, Caputi AP, Bagnardi V, Brea J, et al. Association of community-acquired pneumonia with antipsychotic drug use in elderly patients: a nested case-control study. Ann Intern Med 2010; 152: 418-25, W139-40.
44. Kuo CJ, Yang SY, Liao YT, Chen WJ, Lee WC, Shau WY, et al. Second-generation antipsychotic medications and risk of pneumonia in schizophrenia. Schizophr Bull 2013; 39: 648-57.
45. Jefferson Y. Mouth breathing: adverse effects on facial growth, health, academics, and behavior. Gen Dent 2010; 58: 18-25.
46. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: a population-based prevalence study. JAMA 2000; 284: 2606-10.
47. Pelkonen M, Notkola IL, Lakka T, Tukiainen HO, Kivinen P, Nissinen A. Delaying decline in pulmonary function with physical activity: a 25-year follow-up. Am J Respir Crit Care Med 2003; 168: 494-9.